Earnings History Data for Imago BioSciences, Inc. (IMGO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Imago BioSciences, Inc.

Imago BioSciences Inc. is a clinical stage biopharmaceutical company. It involved in discovering new medicines for the treatment of myeloproliferative neoplasms. Imago BioSciences Inc. is based in SOUTH SAN FRANCISCO, Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-08-2022	AH		IMGO	Imago BioSciences	561.00	-0.41	-0.49	0.00	Imago BioSciences GAAP EPS of -$0.41 beats by $0.09 [8/12/2022 5:00 PM]	19.41	1.05 (5.72%)	18.36	0.0 (0.00%)	11.56 - 35.68	108,220	130,000	1,672
Imago BioSciences Reports Second Quarter 2022 Financial Results and Provides Recent Business Updates [Aug-12-22 04:05PM]
12-05-2022	AH	4:05 PM ET (May 12)	IMGO	Imago BioSciences	491.00	-0.49	-0.42	0.00	Imago BioSciences GAAP EPS of -$0.49 misses by $0.06 [5/12/2022 5:05 PM]	14.71	1.24 (9.21%)	13.47	0.0 (0.00%)	12.85 - 35.68	114,402	150,000	693
Imago BioSciences GAAP EPS of -$0.49 misses by $0.06 [5/12/2022 5:05 PM] Imago BioSciences Reports First Quarter 2022 Financial Results and Provides Recent Business Updates [May-12-22 04:05PM] Imago BioSciences Announces Upcoming Presentations on Updated Data from Phase 2 Studies of Bomedemstat for the Treatment of Essential Thrombocythemia and Myelofibrosis at the 27th Congress of the European Hematology Association (EHA) for 2022 [May-12-22 08:00AM]
10-11-2021	AH		IMGO	Imago BioSciences	751.00	-0.44	-0.36	0.00	Imago BioSciences EPS misses by $0.08 [11/10/2021 4:35 PM]	23.99	2.18 (10.00%)	21.81	0.0 (0.00%)	14.99 - 35.68	30,970	70,000	549
Imago BioSciences EPS misses by $0.08 [11/10/2021 4:35 PM] Imago BioSciences Reports Third Quarter 2021 Financial Results and Provides Recent Business Updates [Nov-10-21 04:05PM] Imago BioSciences to Present at Stifel 2021 Virtual Healthcare Conference [Nov-11-21 04:05PM]